Scancell Share Discussion Threads

[inanaco] 16/3/2018 12:02

LOL ... approx 512,000 now will go to 525,000 Monday all tax free ....

[terror] 16/3/2018 10:24

Now everyone will be happy

[terror] 16/3/2018 09:56

More drama across the Boards.....meanwhile the share price looks set for another leg up.

[farmertally] 15/3/2018 22:32

Now, now Mr Roberts - you don't want to go back to a Windsor hotel again - do you?

[inanaco] 15/3/2018 22:05

What a bit of kit hxxps://youtu.be/4cPSsP256ww

how are your two buffalo Tally ? keep feeding em ! you gotta get the rice out ..

[gooosed] 15/3/2018 20:26

TCR tech making an impression..........

[inanaco] 15/3/2018 18:57

Scancell is a Tardis .. Boom ... (Crumbs 2018)

[bermudashorts] 15/3/2018 18:51

Chelsea, I think you mean 2018.

[bermudashorts] 15/3/2018 18:35

Really??????

[chelsea35] 15/3/2018 18:10

Good posts here today by all...........nearly!!

Bermudashorts..."".Appointing CRO, selecting/finalising trial centres and appointing study investigators."""

If as I think an announcement on SCIB1 is due any day, i would have thought much of that has been decided on. From recent news and videos it does seem Scancell are very confident of getting trial underway by Q4 2017. INHO.

[bermudashorts] 15/3/2018 17:16

Panama,

J&J employ over 125,000 people. Amongst those will be a small army dedicated to running and management of clinical trials based all around the World. Revenue is in the tens of billions - they don't need to wait to raise funds, negotiate with a CRO, trial centres etc. etc. If you're looking at speed of entry into the clinic, it's simply unrealistic to make comparisons between the biggest pharma in the World and a tiny, loss making UK bio employing 15 staff. Of course J&J can mobilise much more quickly IMO it's unfair to accuse Scancell of misleading investors based on that comparison.

sorry, edited to add that we won't know the actual study start date until the clinical trial register is updated.

[panama7] 15/3/2018 16:47

Bermuda, Please explain how J & J can commence their trial in a few days time, do they not also have to go through the same process.

[bermudashorts] 15/3/2018 16:36

"the point is we were told the only thing delaying the trial was Ichor, that is obviously not the case"

Of course it was, the Ichor Master File has only very recently been submitted to the FDA.

[panama7] 15/3/2018 16:31

Bermuda, the point is we were told the only thing delaying the trial was Ichor, that is obviously not the case. We were told by Chiplin that the 2016 fundraising was to enable the Combi trial to commence in 2017. We have been misled by the BOD once again. This trial has been in the planning for 3 years, there are no excuses for any more delays. We were told by Goodfellow in 2015 funding was easy to obtain, yet has still not been sorted. The fact is the BOD miss every single timeline and continue to mislead investors at every opportunity.

[tosh 123] 15/3/2018 16:26

Could not reply ?????
But you've just responded to my reply ! Derrrrr

Leaf was all good until you decided to try and point score, which you failed miserably at yet again , I might add.

Your call. Either you shut up, or otherwise, every time you " try " to be clever, you will be made to look stupid again.

[inanaco] 15/3/2018 15:57

could not reply to my posts, so instead throws a tantrum ...

[inanaco] 15/3/2018 15:55

mmm Tosh's leaf ... 24hr ..

[tosh 123] 15/3/2018 15:54

I'm not sure that you are in any position to correct my grammar especially as you struggle with the most basic of words and their meanings, and furthermore, have used the term " no risk here " , which, to use your own analogy , "is a future unknown "...
Stick to your lies and fairy tales... you're bl00dy great at them.
Leave diction and grammar to others...oh yes, and anything to do with numbers.

[bermudashorts] 15/3/2018 15:54

Panama - as Inanaco has said, Scancell can't do anything until IND submitted and approved by the FDA. Then it will be down to funding and simple logistics. ie. Appointing CRO, selecting/finalising trial centres and appointing study investigators. Physically transporting the vaccine and electroporation kit to each centre and training staff in both study protocol and use of trigrid. etc. etc. Also will depend on availability of the investigators already lined up such as Keith Flaherty and Paul Chapman.

You just can't make any comparisons with J&J - they are literally the largest pharmaceutical company in the World and obviously have the resources and infrastructure to move into trial very rapidly.

[inanaco] 15/3/2018 15:16

Panama7 ... scancell

patient enrolment is now expected to commence in the second half of 2018

4 months away ....

[panama7] 15/3/2018 15:14

Inanaco, on the link provided J & J's trial using Trigrid 2 is due to start on the 19th March so there is absolutely no excuse for our trial not starting till the end of year.

[inanaco] 15/3/2018 15:07

scancell did not have a date when Ichor would get the Go ahead from the FDA

The Company's Investigational New Drug (IND) application for SCIB1 is expected to be filed with the Food and Drug Administration (FDA) during the first half of 2018. Following the pre-IND meeting in 2017, the FDA suggested that technical data from Ichor's new TriGrid 2.0 clinical device should be submitted 30-60 days prior to Scancell's own FDA submission. Ichor are anticipating making its Master File submission imminently which will mean that patient enrolment is now expected to commence in the second half of 2018, subject to receiving sufficient funding.